Gene Technology Advisory Committee (GTAC)

Assesses the scientific merit of New Zealand applications to produce new medical therapies through the transfer of genes from another species to humans, and between species.

Terms of Reference (click here)

Membership as of June 2009

Professor Ian Morison (Chair) University of Otago, Dunedin Professor Stephen Chambers Christchurch School of Medicine & Health Sciences, University of Otago, Christchurch Professor Grant Gillett University of Otago, Dunedin Professor Martin Kennedy University of Otago, Christchurch Emeritus Professor Colin Mantell The University of Auckland Dr Robin Olds Health Research Council of New Zealand Professor Stephen Robertson University of Otago, Dunedin Associate Professor Richard Robson Christchurch Clinical Studies Trust, Christchurch Dr Bruce Scoggins Auckland Dr Deborah Young The University of Auckland

Ex officio Dr Ian Alexander Chair of the CTAC (NHMRC) The Children's Hospital at Westmead New South Wales, Australia Dr David Abbott NHRMC Australia

Guidelines for Preparation of Applications to GTAC

Process and Guidelines 2008 PDF 140KB

Guidelines for Preparation of Applications Involving Clinical Trials of Xenotransplantation in NZ PDF 181KB

Report on LCT Trial Application

On October 21 2008, the Minister of Health gave conditional approval for the company Living Cell Technologies (LCT) to conduct a clinical trial involving the transplantation of pig cells into eight people with diabetes. GTAC has made public its April 2007 report to Medsafe on LCT's application to conduct the trial.

GTAC Report on LCT Application with Cover Letter 030407

For an overview of the application process for clinical trials involving xenotransplantation, click here 

Contact

Megan Willmott, Health Research Council of New Zealand
Email: mwillmott@hrc.govt.nz

Privacy, Copyright, Disclaimer | Site Purpose | Contact us